Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Opendoor Shares Plunge Following Scathing Short-Seller Report

Dieter Jaworski by Dieter Jaworski
September 10, 2025
in Analysis, Nasdaq, Real Estate & REITs
0
Opendoor Stock
0
SHARES
179
VIEWS
Share on FacebookShare on Twitter

A blistering critique from prominent short-selling firm Citron Research has triggered a massive sell-off in Opendoor Technologies Inc., abruptly halting a spectacular rally and refocusing attention on fundamental weaknesses within the company’s business model.

Unprecedented Rally Meets Harsh Reality

The criticism arrives just as Opendoor’s stock was experiencing extraordinary momentum. Propelled by bullish sentiment from notable investors, including Eric Jackson’s EMJ Capital, and weak U.S. jobs data that fueled interest rate cut speculation, the shares had skyrocketed approximately 171% over a single month. This surge had pushed the stock to its highest closing price since August 2022, before Citron’s report abruptly reversed its fortunes.

Citron Research Issues Devastating Critique

The analysis from Citron Research was unequivocal in its condemnation. The firm dismissed Opendoor’s core business model as “nothing more than stock promotion and a scientific experiment in burning cash,” asserting that the approach has “never worked.”

Should investors sell immediately? Or is it worth buying Opendoor?

Key points of the critique include:
* The company’s failure to use artificial intelligence to improve its operating margins.
* The inherent challenges of the low-margin real estate market, which are compounded by the high capital requirements needed to maintain a large inventory of properties.
* A warning of potential further shareholder dilution due to the company’s ongoing cash burn, with a pointed reference to the failure of a similar venture attempted by Zillow.

Fundamental Weaknesses Come to the Fore

The short-seller’s attack immediately returned attention to Opendoor’s own sobering financial projections and recent performance:

  • Revenue Collapse: Management’s guidance for the third quarter anticipates revenue of just $800 million to $875 million—a dramatic fall from the $1.4 billion reported in the same quarter last year.
  • Shrinking Margins: The company’s contribution margin contracted significantly, dropping to 4.4% in the second quarter from 6.3% a year earlier.
  • Diminished Profitability: Contribution profit is also expected to remain substantially below the prior year’s level.

Caught Between Speculation and Scrutiny

Opendoor now finds itself trapped between two opposing forces. On one side is a wave of speculative, meme-stock-like momentum driving volatile price action. On the other is the harsh reality of its business fundamentals, which are drawing increasing skepticism not only from short-sellers but also from established Wall Street analysts. This growing caution is evidenced by recent actions from firms like Keefe, Bruyette & Woods, which downgraded the stock to “Underperform,” and Citigroup, which issued a “Sell” rating.

Ad

Opendoor Stock: Buy or Sell?! New Opendoor Analysis from February 7 delivers the answer:

The latest Opendoor figures speak for themselves: Urgent action needed for Opendoor investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Opendoor: Buy or sell? Read more here...

Tags: Opendoor
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026
Guaranty Bancshares Stock
Analysis

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
ServiceNow Stock
AI & Quantum Computing

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Next Post
Broadcom Stock

Broadcom Shares Surge on Massive AI Chip Contract

Red Cat Stock

Red Cat Holdings Charts New Course with Major Naval Defense Expansion

iShares Global Clean Energy ETF Stock

A Turning Point for the iShares Global Clean Energy ETF?

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com